Lilly Loses Patent Dispute With Actavis Over Cancer Treatment

See on Scoop.it – Advocacy Action & Issues in Cancer Eli Lilly & Co. lost a U.K. lawsuit over its Alimta cancer treatment when a judge ruled that a generic version planned by Actavis Plc doesn’t breach European patents. Heather Swift‘s insight: Court Rules Against Lilly In Cancer Treatment Patent Dispute With Actavis. Bloomberg News … Continue reading

VEGF Inhibitors Trigger Hypertension, Possible Cardiovascular Events – Chemotherapy Advisor

See on Scoop.it – Advocacy Action & Issues in Cancer Antiangiogenic cancer therapies elevate blood pressure in almost all patients, and put some at risk for stroke and myocardial infarction. Heather Swift‘s insight: Antiangiogenic cancer therapies elevate blood pressure in almost all patients, and put some at risk for stroke and myocardial infarction. See on … Continue reading

New study finds 102 common chemicals linked to breast cancer

See on Scoop.it – Advocacy Action & Issues in Cancer New study finds 102 common chemicals linked to breast cancer | A national effort to protect families from toxic chemicals. Heather Swift‘s insight: [CHEMICALS & CANCER] Last week, the Silent Spring Institute published a study that found 102 chemicals linked to breast cancer. What is most … Continue reading

Colorado Legislation Supports Treatment Needs of Terminally Ill Patients

Colorado Legislation Allows Terminally Ill Patients To Try Experimental Medicines. ABC World News (5/18, story 3, 1:55, Muir) reported in its broadcast that Colorado is set to allow access to experimental drugs to terminally ill patients. The report cited the case of cancer victim Nick Auden, who died while awaiting access to an experimental medicine. … Continue reading

Lilly Loses Patent Dispute With Actavis Over Cancer Treatment

See on Scoop.it – Advocacy Action & Issues in Cancer Eli Lilly & Co. lost a U.K. lawsuit over its Alimta cancer treatment when a judge ruled that a generic version planned by Actavis Plc doesn’t breach European patents. See on http://www.bloomberg.com